Search results
Kymera Therapeutics soars as Sanofi expands phase 2 trials
Investing.com via Yahoo Singapore Finance· 6 days agoInvesting.com - Kymera Therapeutics Inc , (NASDAQ:KYMR) a clinical-stage biopharmaceutical firm specializing in the development of novel small molecule medicines using targeted protein degradation ...